Description: Attend this webcast to learn more on how to navigate managing ESG principles in the new normal of a post-COVID world. Enhance your ESG insights in a post-pandemic landscape.

Description: Almost half of recent FDA approvals have been for orphan drugs. This trend is expected to continue in 2023. Orphan drugs are priced more than 30 times higher than non-orphan drugs, therefore their cost burden in aggregate has the potential to overwhelm the budgets of payers, especially that of smaller health plans. Hear how the cost impact analysis for smaller health plans require different considerations than for a larger health plan when modeling the impact of rare diseases.

Description: The Casualty Actuarial Society, the Society of Actuaries Research Institute, the Society of Actuaries Joint Risk Management, Reinsurance and Financial Reporting Sections are pleased to make available key findings from the 2022 Emerging Risks Survey, the sixteenth in the series. Conducted by Max J. Rudolph of Rudolph Financial Consulting LLC, the survey incorporated a set of Emerging Risks defined by the World Economic Forum as the basis for several of the questions. The survey also included questions related to current risk management topics.

Description: This report presents research into recent population mortality experience as it pertains to development of mortality improvement assumptions for measuring obligations of retirement programs in the United States.

Description: The article outlines the editorial vision of Risk Management and Insurance Review (RMIR), emphasizing the need for research that bridges theoretical innovation and real-world application in the evolving landscape of risk management and insurance. RMIR prioritizes methodologically sound work that contributes to conceptual development and offers actionable insights. The journal encourages interdisciplinary, globally diverse, and practically relevant submissions, including those addressing emerging themes like systemic catastrophe risk, behavioral interventions, algorithmic ethics, and the use of AI in insurance.

Description: This report presents Phase 2 of the 2024 IDEC Study, analyzing individual disability income (IDI) claim recovery and mortality rates from 2006-2014. It expands Phase 1's scope—previously limited to 90-day elimination and To Age 65-70 benefit periods—to include additional elimination and benefit periods, examining variations by diagnosis, occupation class, claim year, and gender.

Description: How do Professionalism and the Actuarial Standards of Practice apply as the way we work and tools we use continue to change? Business is conducted via social media and messaging and Generative AI allows for additional scenarios, analysis and oversight. Join us for an interactive session to go deeper into these topics including case studies, polls and a panel discussion.

Description: This data request is for a study focusing on surrender/lapse, withdrawal, living benefit utilization, annuitization, and premium deposit experiences. The study aims to provide detailed analysis and insights into fixed indexed annuity contract activities.

Description: "The Individual Life Experience Committee continues to unlock valuable insights from the VM51 data as the NAIC releases it. In this session, attendees will get a preview of individual life mortality patterns during COVID-19 for more than 100 companies in the NAIC data for the years 2020 to 2021, the first years of the pandemic. The session will also share early findings from the committee's latest initiatives, including the integration of predictive analytics into reporting products, assessment of simplified and accelerated underwriting, exploration of joint life mortality, evaluation of company-level differences, and continued research into old-age mortality patterns. Attendees will leave the session with enhanced knowledge for assessing best-estimate mortality for valuation purposes."

Description: A summary of the newsletter and a rundown of the table manager.